Citations

Institution: Mayo Clinic Clear

Showing 10 of 108094 citations.

Rash and Fever in an Adolescent Traveler
Li, Guyu , Hall, Cody N., Fashina, Oluwatomini A., Klima, Danielle R., Ristagno, Elizabeth H. , Hall, Cody N., Fashina, Oluwatomini A.

Pediatric Infectious Disease Journal | July 23, 2025 | Volume: 44 | Issue: 8 | Pages: 818-820

10.1097/inf.0000000000004844 | PMID 40700645 Get It

Editorial for “Assessment of Intraocular Pressure Using Three‐Dimensional MR Elastography in Ophthalmologically Normal Individuals”
Murphy, Matthew C. , Chan, Kevin C. , Chan, Kevin C , Bang, Ji Won

Journal of Magnetic Resonance Imaging | July 23, 2025 | Volume: 62 | Issue: 5 | Pages: 1494-1495

10.1002/jmri.70050 | PMID 40700642 Get It

Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease
Ma, Lie , Koehn, Brent H. , Zaiken, Michael , Hippen, Keli L. , Smith, Kyle D. , Allred, Jeremy , Williams, Robin , Yao, Ke , Fink, Jordan , Saha, Asim , Payne, Nathaniel, Widelak, Renata, Tolar, Jakub , Xia, Lily , Witty, Alec, Mehta, Amit, Denholtz, Matthew, Hani, Sophia , Kean, Leslie S. , Valamehr, Bahram , Koehn, Brent , Tolar, Jakub , Eide, Cindy , Kenderian, Saad S. , Molldrem, Jeffrey J , Valamehr, Bahram , Blazar, Bruce R , Yao, Ke , Koop, Benjamin, Payne, Nathaniel, Panoskaltsis‐Mortari, Angela , Riddle, Megan J. , Hefazi, Mehrdad , Miller, Jeffrey S. , Molldrem, Jeffrey J. , Blazar, Bruce R.

Blood | July 23, 2025 | Volume: 146 | Issue: 17 | Pages: 2047-2062

10.1182/blood.2025028562 | PMID 40700578 Get It

Abstract Front-line pharmaceutical interventions for treating acute graft-versus-host disease (GVHD) are not uniformly effective and have toxic side effects. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells with potent in vitro and in vivo immunosuppressive functions. Clinical translation of in vitro–generated MDSCs has been limited because of requirements for multiple, high infusion doses, the relatively low yield from peripheral blood–sourced MDSCs (PB-MDSCs), and inconsistent product quality. To circumvent these obstacles, we developed a methodology to generate MDSCs using human induced pluripotent stem cell (iPSC)–derived CD34+ cells. Compared with PB-MDSCs, iPSC-derived MDSCs (iMDSCs) shared similar morphology, phenotype, and suppressive function. We found that the CD14+ iMDSC subset possessed the highest suppressor function. In previous studies, we reported that MDSCs transferred into mice with GVHD lost suppressor function because of inflammasome activation and immature myeloid cell maturation. In striking contrast to human PB-MDSCs, we show herein that iMDSCs retained 95% of suppressor function in vitro despite exposure to lipopolysaccharide (LPS) plus adenosine triphosphate (ATP), which are stimuli that activate the inflammasome via danger-associated molecular patterns released during early posttransplant conditioning and GVHD-induced injury. In an in vivo xenogenic GVHD model with PB mononuclear cells, iMDSCs significantly increased recipient survival without loss of antileukemia effects. iMDSC RNA sequencing and gene knockdown studies revealed that the maintenance of the purine metabolizing enzyme, phosphoglycerate dehydrogenase, during LPS plus ATP treatment, was linked to iMDSC inflammasome resistance. Taken together, these findings provide a platform for translating in vitro–generated, off-the-shelf iMDSCs into the clinic for suppressing a spectrum of adverse immune responses, including GVHD.
Mitochondrial dysfunction drives basal cell hyperplasia in eosinophilic oesophagitis
Morimoto, Masaki , Kawasaki, Kento , McNamee, Niamh , Shimonosono, Rieko, Shimonosono, Masataka , Matsuura, Norihiro, Tomita, Yasuto, Hirose, Wataru , Teranishi, Ryugo , Itami, Takefumi, Guha, Manti , Rajagopalan, Pavithra, Martin, Cecilia , Golden, Hailey, Dhakal, Diya, Wilkins, Benjamin J. , Wangensteen, Kirk J. , Pomenti, Sydney , Katzka, David A. , Que, Jianwen , Whelan, Kelly A. , Muir, Amanda B. , Kita, Hirohito , Wright, Benjamin L. , Doyle, Alfred D. , Teranishi, Ryugo , Abrams, Julian A , Katzka, D A , Wright, Benjamin L , Sachdeva, Uma M , Kita, H , Wangensteen, Kirk J , Que, Jianwen , Flashner, Samuel , Matsuura, Norihiro , Hirose, Wataru, Itami, Takefumi, Golden, Hailey, Klein–Szanto, Andres J. , Nakagawa, Hiroshi

Gut | July 23, 2025 | Volume: 74 | Issue: 10 | Pages: 1571-1588

10.1136/gutjnl-2024-334561 | PMID 40701793 Get It

Background Eosinophilic oesophagitis (EoE) is a food allergen-induced inflammatory disorder characterised by interleukin (IL)-13-mediated oesophageal inflammation and epithelial basal cell hyperplasia (BCH). The role of mitochondria in EoE pathogenesis remains elusive. Design Prompted by single cell transcriptomics data, we interrogated the role of mitochondria in EoE pathobiology using patient biopsies, EoE-mouse models and oesophageal epithelial cells grown in monolayer and three-dimensional (3D) organoid cultures treated with EoE-relevant cytokines. 3D organoids and EoE-bearing mice were treated with omeprazole—a proton-pump inhibitor used as first-line EoE therapy. We performed CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) interference in mouse organoids to identify the key mitochondrial regulatory genes whose depletion may lead to BCH. We analysed mitochondrial membrane potential, mass and superoxide production by flow cytometry, cellular oxygen consumption by respirometry, mitochondrial structures and perturbation of cellular energy homeostasis by immunoblotting. Results Mitochondrial dysfunction appeared to be a hallmark of EoE-related BCH where mitochondrial structural damage was associated with impaired oxidative respiratory capacity, elevation of mitochondrial superoxide and decreased adenosine triphosphate (ATP) production, as corroborated by activation of the adenosine monophosphate (AMP) -activated protein kinase and suppression of mammalian target-of-rapamycin signalling. Depletion of PGC1A, the master regulator of mitochondria biogenesis, recapitulated EoE-related BCH, suggesting that mitochondrial dysfunction drives BCH. Further, omeprazole alleviated mitochondrial damage and dysfunction in EoE-related BCH modelled in mice and patient-derived organoids. Conclusion Mitochondrial dysfunction is tightly linked to perturbation of redox homeostasis in EoE-related BCH, which is promoted by IL-13 and reversible with omeprazole treatment.
Necessary Elements of Intraoperative Cholangiogram: A Call for Synoptic Reporting
Bosley, Maggie E. , Moffett, Jennifer , Porter, Eleah D. , Jorge, Irving , Bloom, Matthew B. , Neff, Lucas P. , Jorge, Irving A

Annals of Surgery Open | July 23, 2025 | Volume: 6 | Issue: 3 | Pages: e599

10.1097/as9.0000000000000599 | PMID 40989875 Get It

Pectus Arcuatum Definitions, Diagnostics, and Surgical Guidelines
Zeineddine, Rawan M. , Khedr, Ahmed E. , Odeh, Nour B., Senjab, Abdulrahman , Jenkins, Jan , Jaroszewski, Dawn E. , Jenkins, J Asher, Farina, Juan M.

JAMA Surgery | July 23, 2025 | Volume: 160 | Issue: 11 | Pages: 1269

10.1001/jamasurg.2025.2365 | PMID 40699568 Get It

Importance Pectus arcuatum is a rare anterior chest wall deformity that is often confused with excavatum, carinatum, or a mixed deformity. A complete understanding of its clinical and physiological basis will improve diagnostic accuracy and allow for standardized management. Objectives To gain a comprehensive understanding of pectus arcuatum, focusing on its nomenclatures, epidemiology, classification, pathophysiology, preoperative presentation and assessments, management options, and surgical outcomes. Evidence Review PubMed, Google Scholar, and subsequent reference searches were used to extract original studies addressing pectus arcuatum fully or partially. The searches were performed on February 2, 2025. Two independent reviewers screened articles based on preestablished inclusion and exclusion criteria. Quality assessment was performed, but given the rarity of arcuatum and the limited, heterogeneous nature of available literature, none of the studies were excluded based on the level of evidence or quality assessments. Using a standardized data extraction form, results were synthesized and presented as a review with recommendations to guide clinical decision-making. Findings A total of 65 studies were included in the final review. Of those, 37 (56.9%) were cohort studies, 18 (27.7%) were case reports, 8 (12.3%) were case series, and 2 (3.1%) were technical reports. A total of 455 cases of pectus arcuatum were represented. Heterogeneity was found in nomenclature, epidemiology, associated conditions, assessments, management, and outcomes. An open surgical approach and, more recently, hybrid open and minimally invasive technique are reported for surgical repair. Postoperative outcomes were good in most surgical series, with no significant difference when compared with the repair of other pectus deformities. Conclusions and Relevance Results of this systematic review reveal that pectus arcuatum is a rare variant of pectus deformities that is distinct from carinatum and excavatum. Unified terminology and standardized diagnostic criteria are important to facilitate proper management. Minimally invasive hybrid approaches continue to refine outcomes, balancing invasiveness with efficacy.
Long-Term Locoregional Outcomes in a Contemporary Cohort of Young Women With Breast Cancer
Dominici, Laura S. , King, Tari A. , Wong, Julia S., Ruddy, Kathryn J. , Peppercorn, Jeffrey , Schapira, Lidia , Come, Steven E. , Collins, Laura C. , Rosenberg, Shoshana M. , Zheng, Yue , Tamimi, Rulla M. , Borges, Virginia F. , Warner, Ellen , Partridge, Ann H.

JAMA Surgery | July 23, 2025 | Volume: 160 | Issue: 9 | Pages: 964

10.1001/jamasurg.2025.2324 | PMID 40699594 Get It

Importance Women diagnosed with breast cancer at a young age are felt to have a higher risk for locoregional recurrence (LRR) regardless of type of local therapy. Objective To assess the long-term incidence of isolated LRR by molecular subtype in a modern multicenter cohort of young women. Design, Setting, and Participants This cohort study, a multicenter prospective study named the Young Women’s Breast Cancer Study, enrolled 1302 women diagnosed with breast cancer at 40 years or younger from 2006 to 2016. Treatment information and incident LRR (ipsilateral breast/chest or lymph node recurrence) were self-reported on study surveys and confirmed with medical record review; molecular subtype was determined by record review. Analysis was reported from February 2023 to May 2025. Main Outcomes and Measures Cumulative incidence of isolated LRR was calculated using the Kaplan-Meier method; hazard ratios were estimated by Cox proportional hazards regression. Results The cohort included 1135 women with stage I through III breast cancer who had a median follow-up of 10.1 years (range, 0.4-16.3 years). The age at diagnosis was younger than 30 years for 145 patients (12.8%), 31 to 35 years for 318 patients (28.0%), and 36 to 40 years for 672 patients (59.2%). There were 59 isolated local recurrences (5.2%) and 4 isolated regional recurrences (0.4%). Among patients with local therapy and subtype data available (n = 1128), 366 (32%) had luminal A–like tumors; 240 (21%), luminal B–like tumors; 231 (20%) luminal ERBB2 positive (+)–like (formerly HER2 positive); 90 (8%) ERBB2 +-like; and 201 (18%) triple negative. A total of 346 women (30%) had breast-conserving therapy (BCT) (98% of whom had radiation), 296 (26%) unilateral mastectomy, and 487 (43%) bilateral mastectomy. Of women who had mastectomy, 425 (54%) had radiation. The cumulative incidence of LRR at 10.1 years by subtype was as follows: luminal A, 4.4% (range, 1.0%-6.9%); luminal B, 4.7% (range 1.8%-7.7%); luminal ERBB2 +, 6.1% (range, 3.1%-8.3%); ERBB2 +, 2.2% (range, 0%-6.3%); and triple negative, 6.5% (range, 4.2%-10.1%). The cumulative incidence of LRR by locoregional treatment type at 10.1 years was 6.7% after BCT (range, 4.3%-10.1%), 6.5% after mastectomy without radiation (range, 0%-7.7%), and 2.4% after mastectomy with radiation (range, 1%-4.2%). Although mastectomy with radiation was associated with the lowest risk of LRR on multivariable analysis, when examined within molecular subtype, there were no differences seen. Conclusions and Relevance In this contemporary cohort of women diagnosed with breast cancer at age 40 years or younger, risk of isolated LRR was relatively low (5.6%) at a median follow-up of 10.1 years, and significant differences were not seen by tumor subtype. Concerns for long-term risk of LRR should not influence surgical decision-making with young women, irrespective of molecular subtype.
Twice‐daily administration improves the effectiveness of 0.01% atropine for controlling myopia in slowing axial elongation and refractive progression
Xu, Shengsong , Wang, M Y , Qu, Yan , Jiang, Jinyun , Zhao, Wenchen , Zheng, Bingru , Lei, Xingyu, Li, Zhouyue , Hu, Yin , Wang, Mengyi , Zhou, Fengqi, Zheng, Bingru , Yang, Xiao , Qu, Yiwen, Wang, Yanbin , Zhou, Fengqi , Chen, Weiyin, Lei, Xingyu

Ophthalmic and Physiological Optics | July 23, 2025 | Volume: 45 | Issue: 7 | Pages: 1856-1866

10.1111/opo.13558 | PMID 40698880 Get It

Abstract Purpose It remains unclear whether increasing the frequency of administration of 0.01% atropine improves its effectiveness in slowing axial elongation or refractive progression. This study compared twice‐daily 0.01% atropine administration and traditional once‐nightly administration. Methods A hybrid design was adopted incorporating both retrospective and prospective elements, with participants observed for 1 year. The control group (received saline eye drops) and once‐daily 0.01% atropine group (Atropine‐1 group) were derived from two previous trials, while the twice‐daily 0.01% atropine group (Atropine‐2 group) was enrolled prospectively. A total of 163 participants were included in the intention‐to‐treat set, with 51, 70 and 42 participants in the control, Atropine‐1 and Atropine‐2 groups, respectively. The primary outcome was the change in axial length (AL), and the secondary outcome was the change in cycloplegic spherical equivalent refraction (SER). Results Compared with the control group (0.48 ± 0.22 mm), both Atropine‐1 (0.26 ± 0.17 mm) and Atropine‐2 (0.15 ± 0.18 mm) groups showed significantly reduced AL elongation ( p < 0.001). Notably, Atropine‐2 significantly improved slowing of AL elongation compared with Atropine‐1 ( p = 0.008). The result of the secondary outcome (adjusted SER change) was consistent. Atropine‐2 was significantly more effective in slowing SER progression (−0.15 ± 0.37 D) than Atropine‐1 (−0.41 ± 0.50 D) ( p = 0.02). Based on a multivariable model, age was identified as the key covariate to perform subgroup analyses. In the younger subgroup (8–10 years), AL elongation was significantly reduced in the Atropine‐2 group (0.16 ± 0.17 mm) compared with the Atropine‐1 group (0.36 ± 0.22 mm; p = 0.002). In the older subgroup (10–12 years), there was no significant difference in progression. Consistent results were observed in the sensitivity analyses based on the per‐protocol set. Conclusion Twice‐daily administration of 0.01% atropine was more effective than once daily in slowing AL elongation and SER progression in children 8 to 10 years of age. Further investigation with extended follow‐up is warranted to substantiate this finding.
Robotic Surgery in Emergency Colorectal Procedures: Analysis of Outcomes and Future Trends
Violante, Tommaso , Novelli, Marco , Sileo, Annaclara , Violante, Tommaso , Ferrari, Davide, Sassun, Richard , Larson, David W.

Journal of the American College of Surgeons | July 23, 2025 | Volume: 241 | Issue: 6 | Pages: 1013-1025

10.1097/xcs.0000000000001500 | PMID 40698773 Get It

BACKGROUND: Emergency colorectal surgery traditionally uses open approaches, with limited minimally invasive adoption. Although robotic surgery demonstrates benefits in elective procedures, its role in emergency settings remains unclear. This retrospective study evaluated outcomes of robotic vs laparoscopic and open approaches in emergency colorectal procedures and predicted future adoption trends. STUDY DESIGN: We analyzed 83,483 patients from the American College of Surgeons NSQIP database (2012 to 2021) who underwent emergency colorectal surgery: 53,731 open, 26,649 laparoscopic, and 3,103 robotic procedures. Outcomes were analyzed using multivariable regression, propensity score matching, and g-computation analysis. Classification and Regression Trees were used to analyze surgical approaches to selection factors, whereas vector autoregressive models projected future usage trends. RESULTS: Robotic surgery demonstrated significantly lower conversion rates to open surgery compared with laparoscopy (7.8% vs 24.2%; adjusted odds ratio 0.32, 95% CI 0.28 to 0.36), shorter length of stay (incidence rate ratio 0.67, 95% CI 0.65 to 0.69), and fewer surgical complications (odds ratio 0.65, 95% CI 0.60 to 0.72). Robotic usage increased from 0% to 6.6% (2012 to 2021), with trends suggesting substantial growth toward 20.2% by 2025. Patient selection favored robotics for stable patients with diverticulitis (68.4%) and cancer without sepsis, whereas open surgery remained predominant in patients with perforation, severe sepsis, or significant comorbidities. CONCLUSIONS: In selected emergency colorectal procedures, robotic surgery demonstrates superior outcomes vs conventional approaches. These outcomes may be partially influenced by patient selection factors because robotic cases involved more clinically stable patients. These findings support expanded robotic platform availability for emergency procedures, although careful patient selection remains essential. The projected increase in robotic usage reflects a growing acceptance of this technology, suggesting that its technical advantages can extend to more complex emergency cases than previously considered.
Super Learner Enhances Postoperative Complication Prediction in Colorectal Surgery
Violante, Tommaso , Novelli, Marco , Perry, William , Mathis, Kellie L. , Dozois, Eric J. , Violante, Tommaso , Perry, William R , Ferrari, Davide , Larson, David W.

Annals of Surgery | July 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/sla.0000000000006847 | PMID 40698768 Get It

Objective: To determine if a Super Learner (SL) machine learning approach could improve the predictive accuracy of the American College of Surgeons Risk Calculator (ACS-RC) for postoperative complications in patients undergoing colorectal surgery. Summary of Background Data: Machine learning (ML) has shown significant potential to advance medical fields, including surgical risk prediction. Current tools, like the ACS-RC which uses logistic regression and extreme gradient boosting, are standard but may be enhanced by more advanced ML ensembles. Methods: This retrospective study analyzed colorectal surgery cases from the 2018-2022 ACS National Surgical Quality Improvement Program (NSQIP) database. An SL model, which combines multiple ML algorithms, was developed to predict fourteen postoperative outcomes. Its performance was compared against traditional logistic regression (LOG) and extreme gradient boosting (XGB) models. Key performance metrics included discrimination (AUROC, AUPRC) and calibration (Brier score, Hosmer-Lemeshow test). Results: The SL model demonstrated superior performance across all predicted complications when compared to both LOG and XGB. It showed superior discrimination for severe outcomes, achieving an AUROC greater than 0.94 for predicting mortality. The SL model was also more accurate in predicting infectious complications and length of stay, and its calibration metrics indicated a better overall fit and accuracy. Conclusions: The Super Learner model enhances the accuracy of postoperative risk prediction in colorectal surgery. Its superior performance suggests it is a promising tool for improving personalized patient counseling, aiding clinical decision-making, and optimizing resource allocation.